Group B
Strep
Childbirth practitioners globally continue to debate the issue
of how to effectively handle the testing and treatment of Group Beta Strep
(GBS). Opinions and protocols vary
widely even among midwives.
Our approach is to provide clients with
literature, including risks, benefits, and available treatment plans.
We give women a choice of whether they want a routine culture at around
36 weeks or to be treated on an at risk basis, or not at all.
We feel that in letting the parents decide if they want to test and what
they want to do about it, we are not making decisions for them.
If you
choose to have a culture and it returns positive, we will refer you to a
physician as we cannot administer antibiotics and that is the standard medical
protocol in our area.
We do not underestimate the serious nature of GBS.
Each client signs a consent form that states that they understand that
there is no “perfect” answer for strep – no perfect screening program, no
protocol that will alleviate all perinatal strep-infected babies; that no method
of screening and/or prophylactic treatment is 100% effective in preventing GBS.
All we can do is continue to seek improved methods to try and reduce the
incidence.
Because of the potential health hazards in giving even one
unnecessary antibiotic in these days of increasingly drug-resistant pathogens,
it is vitally important that birth practitioners find safe, alternative
treatments in the attempt to reduce colonization and eradicate the threat of GBS
infected babies. According to the FDA,
“part of the problem is that bacteria and other microorganisms that cause
infections are remarkably resilient and can develop ways to survive drugs meant
to kill or weaken them. This
antibiotic resistance, also known as
antimicrobial resistance or
drug resistance is due largely to the
increasing use of antibiotics.”
Group B Streptococcus
(GBS) is a type of bacteria found in 10 – 35% of all healthy, adult women. A
person can have these bacteria without having signs of an infection. Group B
Strep is not the same bacteria that causes strep throat
A
baby is exposed to GBS during labor and delivery. A baby is more unprotected
after the water breaks or if the baby is premature. If a newborn is exposed to
GBS and develops the disease, the baby will have a life-threatening infection in
the bloodstream, in the lungs, and/or in the brain. If a baby is premature,
there is an even higher risk for long-term complications and/or death.
Many women test positive for GBS. But only 1 in 4000 babies actually
contracts the GBS virus. The death rate is relatively high for that one baby
(some say as close to 50 percent).
The following are some
herbal remedies suggested to prevent GBS.
Chlorhexidine
douche
(Hibiclens).
To use this option,
at the beginning of labor you would use a hot water or enema bottle
partially full of distilled water and 140ml of chlorhexidine.
You would perform a vaginal douche using this entire solution.
Every six hours during labor you would make a new solution and
perform a vaginal douche. You
would keep doing this until the birth.
Another option is to place the 140 ml of chlorhexidine into a peri-wash
bottle and spray it onto the vaginal/rectal area every six hours – this
option should be used if your bag of membranes has ruptured.
According to a 2006 study published by the American College of OB/GYNs:
When used
as a vaginal or newborn disinfectant, it clearly reduces
bacterial load, including transmission of Group B
Streptococcus from the
mother to the fetus. Nevertheless, in developed countries,
chlorhexidine generally has not been shown to significantly
reduce life-threatening maternal or neonatal infections. However,
2 large but not randomized studies, one in Malawi and the other
in Egypt, suggest that important reductions in maternal and
neonatal sepsis and neonatal mortality may be achievable with
vaginal or neonatal chlorhexidine treatment.
According to a study published in the 2002
Journal of Maternal Fetal Neonatal Medicine:
In
this carefully screened target population, intrapartum vaginal flushings
with chlorhexidine in colonized mothers display the
same efficacy as ampicillin in
preventing vertical transmission of group B streptococcus. Moreover, the
rate of neonatal E. coli colonization was reduced by chlorhexidine.
According to a study published in the 1997
British Medical Journal:
Cleansing the birth canal with chlorhexidine
reduced early neonatal and
maternal postpartum infectious problems. The safety, simplicity, and low
cost of the procedure suggest that it should be considered as standard care
to lower infant and maternal morbidity and mortality.
In this study the maternal birth canal was wiped with a
chlorhexidine solution at every vaginal examination before delivery. Babies
born during the intervention were also wiped with chlorhexidine.
According to a 1999 study from the
University of Oslo, Norway: In this
study women used a chlorhexidine solution sprayed onto their vaginal/rectal
areas using a peri-wash bottle.
This study noted a decline in Urinary Tract Infections as well as a
significant reduction in maternal and early neonatal infectious morbidity.
The squeeze bottle procedure was simple, quick, and well tolerated. The
beneficial effect may be ascribed both to mechanical cleansing by liquid
flow and to the disinfective action of chlorhexidine.
According to a 1992 study publisned in The Lancet:
Chlorhexidine reduced the admission
rate for infants born of carrier mothers to 2.8% (RR 1.95, 95% Cl
0.94-4.03), and for infants born to all mothers to 2.0% (RR 1.48, 95% Cl
1.01-2.16; p n 0.04). Maternal S. agalactiae colonization is associated with
excess early neonatal morbidity, apparently related to aspiration of the
organism that can be reduced with chlorhexidine disinfection of the vagina
during labor.
You can purchase Chlorhexidine (Hibiclens) online and at most
drug stores.